Novanta Inc. Files 8-K: Office Relocation

TL;DR

NOVANTA INC. MOVED OFFICES TO BEDFORD, MA.

AI Summary

On November 13, 2025, Novanta Inc. filed an 8-K report. The filing indicates a change in the company's principal executive offices to 125 Middlesex Turnpike, Bedford, Massachusetts 01730. This report was filed as of November 13, 2025.

Why It Matters

This filing signals a change in Novanta Inc.'s operational base, which could impact local employment and business operations.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of a change in corporate address and does not indicate any material financial or operational changes.

Key Players & Entities

• Novanta Inc. (company) — Registrant
• 125 Middlesex Turnpike, Bedford, Massachusetts 01730 (location) — New principal executive offices
• November 13, 2025 (date) — Date of report

FAQ

Key Financial Figures

• $0.84 — he fourth quarter and full year 2025 is $0.84 to $0.91 and $3.21 to $3.28, respective
• $0.91 — quarter and full year 2025 is $0.84 to $0.91 and $3.21 to $3.28, respectively. The p
• $3.21 — nd full year 2025 is $0.84 to $0.91 and $3.21 to $3.28, respectively. The prior Adjus
• $3 — ear 2025 is $0.84 to $0.91 and $3.21 to $3.28, respectively. The prior Adjusted Di
• $0.87 — e fourth quarter and full year 2025 was $0.87 to $0.93 and $3.24 to $3.30, respective
• $0.93 — quarter and full year 2025 was $0.87 to $0.93 and $3.24 to $3.30, respectively. The
• $3.24 — d full year 2025 was $0.87 to $0.93 and $3.24 to $3.30, respectively. The fourth qu
• $253 million — he fourth quarter and full year 2025 of $253 million to $257 million and $975 million to $97
• $257 million — r and full year 2025 of $253 million to $257 million and $975 million to $979 million, respe
• $975 million — 025 of $253 million to $257 million and $975 million to $979 million, respectively; and ther
• $979 m — ion to $257 million and $975 million to $979 million, respectively; and there is no ch
• $62 million — he fourth quarter and full year 2025 of $62 million to $65 million and $222 million to $225
• $65 million — er and full year 2025 of $62 million to $65 million and $222 million to $225 million, respe
• $222 million — 2025 of $62 million to $65 million and $222 million to $225 million, respectively. Non-GA
• $225 m — lion to $65 million and $222 million to $225 million, respectively. Non-GAAP Informa

Filing Documents

• novt-20251113.htm (8-K) — 51KB
• 0001193125-25-280353.txt ( ) — 159KB
• novt-20251113.xsd (EX-101.SCH) — 29KB
• novt-20251113_htm.xml (XML) — 4KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. Novanta Inc. ("Novanta" or the "Company") revised certain fourth quarter and full year 2025 financial guidance to reflect the completion of the recent equity issuance. The updated non-GAAP adjusted diluted earnings per share ("Adjusted Diluted EPS") guidance for the fourth quarter and full year 2025 is $0.84 to $0.91 and $3.21 to $3.28, respectively. The prior Adjusted Diluted EPS guidance for the fourth quarter and full year 2025 was $0.87 to $0.93 and $3.24 to $3.30, respectively. The fourth quarter and full year 2025 guidance reflects a weighted average diluted shares outstanding share impact in an expected range between 2.5 million and 2.6 million and 0.6 million and 0.7 million shares, respectively. The full year 2026 diluted shares outstanding impact is estimated between 4.7 million and 5.9 million shares. There is no change to our GAAP revenue guidance for the fourth quarter and full year 2025 of $253 million to $257 million and $975 million to $979 million, respectively; and there is no change to our Adjusted EBITDA guidance for the fourth quarter and full year 2025 of $62 million to $65 million and $222 million to $225 million, respectively. Non-GAAP Information Novanta provides earnings guidance on a non-GAAP basis and does not provide earnings guidance on a GAAP basis, with the exception of GAAP revenue guidance. A reconciliation of the Company's forward-looking Adjusted EBITDA and Adjusted Diluted EPS guidance to the most directly comparable GAAP financial measures is not provided because of the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliations, including acquisitions and related expenses; impact of purchase price allocations for recently completed acquisitions; future changes in the fair value of contingent considerations; future restructuring expenses; foreign exchange gains/(losses); significant discrete income tax expenses (benefits); benefits o

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Novanta Inc. Date: November 13, 2025 By: /s/ Robert J. Buckley Robert J. Buckley Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR